We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Roche's Tecentriq

News List

Roche's Tecentriq cocktail hops into the FDA fast lane for another Merck showdown fiercepharma
May 08, 2018
The company said Monday that the triplet won FDA priority review for previously untreated patients with advanced lung cancer, and that means it could go toe-to-toe with Merck & Co. by Sept. 5.
NICE draft guidance rejects Roche's Tecentriq for bladder cancer firstwordpharma
August 03, 2017
The National Institute for Health and Care Excellence issued draft guidance Wednesday recommending against NHS reimbursement of Roche's Tecentriq (atezolizumab) for treating locally advanced or metastatic urothelial carcinoma in adults after prior platinu